BioSig Technologies, Inc. (BSGM)
USD 0.51
(-3.33%)
USD 0.51
(-3.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 18 Thousand USD | -249.78% |
| 2022 | 229 Thousand USD | -5.37% |
| 2021 | 242 Thousand USD | 144.0% |
| 2020 | -550 Thousand USD | -911.98% |
| 2019 | -54.34 Thousand USD | -338.19% |
| 2018 | -12.4 Thousand USD | -6.03% |
| 2017 | -11.69 Thousand USD | -11.68% |
| 2016 | -10.47 Thousand USD | 0.0% |
| 2015 | -10.47 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -36 Thousand USD | 43.75% |
| 2024 Q1 | -64 Thousand USD | 20.99% |
| 2023 FY | -343 Thousand USD | -249.78% |
| 2023 Q2 | -165 Thousand USD | -10.0% |
| 2023 Q3 | -91 Thousand USD | 44.85% |
| 2023 Q4 | -81 Thousand USD | 10.99% |
| 2023 Q1 | -150 Thousand USD | -238.89% |
| 2022 Q2 | -144 Thousand USD | -9.09% |
| 2022 Q1 | -132 Thousand USD | 14.84% |
| 2022 Q4 | 108 Thousand USD | 2.86% |
| 2022 Q3 | 105 Thousand USD | 172.92% |
| 2022 FY | 229 Thousand USD | -5.37% |
| 2021 Q2 | 145 Thousand USD | 663.16% |
| 2021 FY | 242 Thousand USD | 144.0% |
| 2021 Q3 | 70 Thousand USD | -51.72% |
| 2021 Q4 | -155 Thousand USD | -321.43% |
| 2021 Q1 | 19 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | -550 Thousand USD | -911.98% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2019 FY | -54.34 Thousand USD | -338.19% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 FY | -12.4 Thousand USD | -6.03% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | -11.69 Thousand USD | -11.68% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | -10.47 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | -10.47 Thousand USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 100.574% |
| Cerus Corporation | 86.4 Million USD | 99.979% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.984% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 97.566% |
| Talis Biomedical Corporation | 371 Thousand USD | 95.148% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 99.782% |
| Inogen, Inc. | 126.69 Million USD | 99.986% |
| Spectral AI, Inc. | 7.88 Million USD | 99.772% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 100.273% |
| CVRx, Inc. | 33.03 Million USD | 99.946% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | 70.492% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.996% |
| Venus Concept Inc. | 52.16 Million USD | 99.965% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 99.294% |
| Bioventus Inc. | 328.19 Million USD | 99.995% |
| BrainsWay Ltd. | 23.09 Million USD | 99.922% |
| Envoy Medical, Inc. | -473 Thousand USD | 103.805% |
| electroCore, Inc. | 13.22 Million USD | 99.864% |
| IceCure Medical Ltd | 1.3 Million USD | 98.615% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 100.298% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 138.026% |
| MaxCyte, Inc. | 36.54 Million USD | 99.951% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 96.057% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 78.838% |
| PAVmed Inc | -3.96 Million USD | 100.454% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 100.328% |
| RxSight, Inc. | 53.76 Million USD | 99.967% |
| Sight Sciences, Inc. | 69.17 Million USD | 99.974% |
| SI-BONE, Inc. | 109.42 Million USD | 99.984% |
| TELA Bio, Inc. | 40.11 Million USD | 99.955% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 99.887% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.988% |
| LivaNova PLC | 771.25 Million USD | 99.998% |
| 908 Devices Inc. | 25.32 Million USD | 99.929% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.994% |
| Nemaura Medical Inc. | -1.47 Million USD | 101.219% |
| NeuroPace, Inc. | 48.12 Million USD | 99.963% |
| LENSAR, Inc. | 21.1 Million USD | 99.915% |
| Apyx Medical Corporation | 14.12 Million USD | 99.873% |
| Cutera, Inc. | 41.49 Million USD | 99.957% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 99.902% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 99.983% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 99.868% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.998% |
| Axonics, Inc. | 274.55 Million USD | 99.993% |
| Outset Medical, Inc. | 29 Million USD | 99.938% |
| IRIDEX Corporation | 21.8 Million USD | 99.917% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 99.975% |
| IRadimed Corporation | 50.15 Million USD | 99.964% |
| Tivic Health Systems, Inc. | 287 Thousand USD | 93.728% |
| INVO Bioscience, Inc. | 1.08 Million USD | 98.343% |
| Telesis Bio, Inc. | 16.95 Million USD | 99.894% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.984% |
| Varex Imaging Corporation | 256.9 Million USD | 99.993% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.989% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 104.433% |
| Pulmonx Corporation | 50.75 Million USD | 99.965% |
| Dynatronics Corporation | 7.63 Million USD | 99.764% |
| Modular Medical, Inc. | -768 Thousand USD | 102.344% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 99.676% |
| Semler Scientific, Inc. | 61.2 Million USD | 99.971% |
| InMode Ltd. | 411.34 Million USD | 99.996% |
| Bruker Corporation | 1.51 Billion USD | 99.999% |
| Cytosorbents Corporation | 22.39 Million USD | 99.92% |
| DexCom, Inc. | 2.28 Billion USD | 99.999% |
| Align Technology, Inc. | 2.71 Billion USD | 99.999% |
| Viveve Medical, Inc. | 620 Thousand USD | 97.097% |
| ZimVie Inc. | 290.38 Million USD | 99.994% |
| Movano Inc. | -158 Thousand USD | 111.392% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.984% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 78.838% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.995% |
| Profound Medical Corp. | 4.51 Million USD | 99.601% |
| Insulet Corporation | 1.15 Billion USD | 99.998% |
| enVVeno Medical Corporation | -546 Thousand USD | 103.297% |
| Surmodics, Inc. | 93.05 Million USD | 99.981% |
| iCAD, Inc. | 14.53 Million USD | 99.876% |
| Nuwellis, Inc. | 4.98 Million USD | 99.639% |
| Biotricity, Inc. | 8.35 Million USD | 99.785% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.995% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 105.013% |
| InspireMD, Inc. | 1.8 Million USD | 99.004% |
| PAVmed Inc. | -3.96 Million USD | 100.454% |
| BIOLASE, Inc. | 16.72 Million USD | 99.892% |
| Beyond Air, Inc. | -1.3 Million USD | 101.377% |
| FONAR Corporation | 45.14 Million USD | 99.96% |
| AxoGen, Inc. | 127.87 Million USD | 99.986% |
| Vivani Medical, Inc. | -357 Thousand USD | 105.042% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.991% |
| Inari Medical, Inc. | 434.56 Million USD | 99.996% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.984% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -43.781% |
| Tenon Medical, Inc. | 1.24 Million USD | 98.55% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 122.222% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 99.315% |
| AdaptHealth Corp. | 479.56 Million USD | 99.996% |
| Sintx Technologies, Inc. | 1.84 Million USD | 99.023% |
| NanoVibronix, Inc. | 1.53 Million USD | 98.829% |
| Quanterix Corporation | 70.64 Million USD | 99.975% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 104.433% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 99.872% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 99.966% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.988% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 99.596% |
| NeuroMetrix, Inc. | 3.94 Million USD | 99.544% |
| Hyperfine, Inc. | 4.75 Million USD | 99.622% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 99.983% |
| Biomerica, Inc. | 611 Thousand USD | 97.054% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 99.957% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 102.305% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.986% |